| 13.90 Delayed Data As of 3:59pm ET |  +0.23 / +1.68%Today’s Change | 8.00 Today|||52-Week Range 15.86 | +22.09% Year-to-Date |
| Previous close | 13.67 |
| Today’s open | 13.52 |
| Day’s range | 13.00 - 13.99 |
| Volume | 15,215 |
| Average volume (3 months) | 31,603 |
| Market cap | $116.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -93.33% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3,514.14 |
| Today’s change | Today’s % change | |
|---|---|---|
| ZSANZosano Pharma Corp | -0.01 | -0.10% |
| NVETNexvet Biopharma plc | -0.05 | -0.47% |
| ARQLArQule Inc | +0.04 | +2.14% |
| GTXIGTX Inc | -0.04 | -5.00% |
| Last reporting date | March 4, 2015 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.0M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, CEO, Secretary & Director David P. Luci |
Vice President-Finance & Corporate Development David Garrett |
Corporate headquarters New York, New York |
